For Immediate Release
Hong Kong Patients Benefit from Next Generation Ceramic-on-ceramic Hip Resurfacing System as Matilda Hospital Expands Advanced Joint Solutions
Hong Kong, 19th May, 2026 – Matilda International Hospital has successfully introduced the MatOrtho ReCerf® all-ceramic hip resurfacing system to Hong Kong, marking a significant regional medical milestone as the first application of this technology in Asia. Recently awarded the CE Mark, this breakthrough device forms a core component of the hospital’s comprehensive expansion in lower-limb orthopaedic capabilities, which also features advanced robotic-arm technology for both hip and knee replacements.
For decades, younger patients suffering from hip dysplasia or early osteoarthritis faced a complex clinical challenge when seeking bone-conserving surgical options. The introduction of the all-ceramic ReCerf® system, utilising advanced Biolox® delta ceramic, provides a highly durable, ceramic-on-ceramic bearing that addresses long-standing limitations in joint preservation.
"Hip resurfacing is a technically demanding procedure with a slower initial recovery than a conventional total hip replacement, but offers outstanding function, allowing most patients to return to unrestricted sports and activities." explains Dr. Jason Brockwell, Orthopaedic Surgeon. "In addition, hip resurfacings conserve bone, potentially making any future revision procedure much simpler. We have a long history with this bone-conserving approach, having introduced the metal-on-metal Birmingham Hip Resurfacing® to Hong Kong at Matilda in 2003 and completing over 500 cases."
Dr Brockwell continues, "Historically, metal-on-metal resurfacing implants were highly successful for many young men, but were not suitable for many female patients due to anatomical sizing and material sensitivities. The MatOrtho ReCerf® changes this. Its highly biocompatible ceramic and versatile sizing expand this bone-conserving option to women. The surgical technique is very similar to traditional resurfacing, meaning the learning curve is short, and early clinical outcomes for female patients so far are encouraging."
Beyond niche joint preservation, Matilda has cultivated a comprehensive orthopaedic ecosystem to address the full spectrum of joint degradation. For patients whose condition has progressed to require a total joint replacement, the hospital's investment in state-of-the-art robotic-arm assisted surgery provides an advanced level of precision for both hips and knees. By integrating meticulous 3D pre-operative planning with the tactile precision of a robotic arm, surgeons can protect healthy soft tissue, optimally balance ligaments, and ensure exact leg length. This millimetre accuracy promotes a smoother, more predictable recovery, allowing patients to regain their mobility with confidence.
"At the heart of this technological expansion is our unwavering commitment to person-centred care," notes Ms Linda Burgoyne, Chief Executive Officer. "Navigating joint pain can be a daunting journey, and we believe in empowering patients with clear choices and complete transparency. Introducing the ReCerf® system as a first-in-Asia technology is part of our continuous investment in world-class orthopaedic care. By combining these advanced surgical options with transparent, fixed-price care programmes, we ensure that clinical excellence remains accessible, giving our patients complete peace of mind from their initial consultation right through to rehabilitation."
For more information on advanced joint preservation and robotic orthopaedic options, please visit www.matilda.org.
- End -
About Matilda International Hospital
Matilda International Hospital is a not-for-profit private hospital providing person-centred care to international standards. Key areas of expertise include Orthopaedics and Spine, Women’s Health and Maternity, General Surgery, and Ear, Nose, and Throat, supported by state-of-the-art technology and robotic assistance. Seamless medical services are supported by 24/7 outpatient department and a conveniently located medical centre in Central.
Media Enquiries
| Ms. Selina Li, Head of Marketing & Communications | 2849 0357 / 9464 5246 |
| Ms. Cleo Lam, Senior Officer, Public Relations & Branding | 2849 0390 / 6391 3911 |
Email: media@matilda.org
*Source reference:
Average Length of Stay: American Academy of Orthopaedic Surgeons. (2026, March). Research news: Robotic-arm assisted surgery and clinical outcomes. AAOS 2026 Annual Meeting Press Kit.
Time to Mobilisation: National Library of Medicine. (2026, Jan). Mobilisation After Total Knee Replacement Within an Enhanced Recovery Pathway: A Two-Cycle Clinical Audit. PubMed.
Return to Work: Society of Robotic Surgery. (2026). Clinical surveys on patient recovery and functional milestones post-robotic surgery.
Infection Rates: OrthoFeed. (2026, March 28). Robotic-assisted arthroplasty shows higher patient satisfaction and quality of life for total knee replacement; comparable infection rates to conventional surgery for total hip replacement.
30-Day Readmission: National Library of Medicine. (2026, Feb). National evidence linking robotic total knee arthroplasty to reduced 90-day readmissions, complications, and readmission costs. PubMed.
Patient Satisfaction and Pain Reduction: American Academy of Orthopaedic Surgeons. (2026, March). Robotic-assisted arthroplasty shows higher patient satisfaction and quality of life for total knee replacement; comparable infection rates to conventional surgery for total hip replacement. AAOS 2026 Annual Meeting Press Kit. In a prospective analysis of 1,154 patients, robotic-assisted TKA achieved a 93.5% satisfaction rate in patients under 75, significantly outperforming conventional surgery in early pain relief and quality of life.